drugset / Trial / NCT01417078

A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode

NCT01417078

Phase 2 Completed 31 enrolled Acorda Therapeutics
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the pharmacokinetics of Diazepam Nasal Spray following a single dose in epileptic patients experiencing a seizure episode.

Timeline

Start
2011-09
Primary completion
2013-02
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule Intranasal

Indications